13 results · 16ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

FDA classification
FDA Class 3 ·Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

Droplet Digital Pcr System

FDA classification
FDA Class 2 ·Droplet Digital Pcr System

Stylet, Tracheal Tube

FDA classification
FDA Class 1 ·Stylet, Tracheal Tube

Stimulator, Carotid Sinus Nerve

FDA classification
FDA Class 3 ·Stimulator, Carotid Sinus Nerve

Transport Medium, Notified Per The Vtm Guidance

FDA classification
FDA Class 1 ·Transport Medium, Notified Per The Vtm Guidance

Test, Factor V Leiden Mutations, Genomic Dna Pcr

FDA classification
FDA Class 2 ·Test, Factor V Leiden Mutations, Genomic Dna Pcr

Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

FDA classification
FDA Class 2 ·Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr

FDA classification
FDA Class 2 ·Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA classification
FDA Class 2 ·Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set

FDA classification
FDA Class 2 ·Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set

Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

FDA classification
FDA Class 3 ·Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

System, Blood Collection, Rna Stabilization, Rna Purification, Rt-Pcr Molecular Diagnostic Test

FDA classification
FDA Class 2 ·System, Blood Collection, Rna Stabilization, Rna Purification, Rt-Pcr Molecular Diagnostic Test

Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

FDA classification
FDA Class 2 ·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers